Company / Capital Returned to Shareholders
Ensign Group Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$34.4M
FY2025
5-year range
$12.9M / $42.0M
FY2021-FY2025
Trend
+151.7%
vs FY2024
Sector context
#73 of 108
Health Care
What the data says
At $34M, Ensign Group's capital returned to shareholders ranks #73 of 108 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $9M in FY2018 to $42M in FY2022.
Based on SEC 10-K filings.
$34M in FY2025 with a 5-year CAGR of -0.8%.
Improved from $13M to $34M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -6.5%
- 5-Year CAGR
- -0.8%
- 10-Year CAGR
- -
Sector benchmark
#73 of 108 in Health CareTop 68% of 108This company $34.4M Sector average $754.9M
▼
-95.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.8%, indicating a declining trend.
- In FY2025, capital returned to shareholders increased 151.7% year-over-year.
- Ranks #73 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.4M | +151.7% |
| FY2024 | $13.7M | +6.1% |
| FY2023 | $12.9M | -69.3% |
| FY2022 | $42.0M | +94.1% |
| FY2021 | $21.7M | -39.5% |
| FY2020 | $35.8M | +115.9% |
| FY2019 | $16.6M | +76.2% |
| FY2018 | $9.4M | -41.1% |
| FY2017 | $16.0M | -58.1% |
| FY2016 | $38.2M | +409.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026